Duvelisib, a novel oral dual inhibitor of PI3K-{delta},{gamma}, is clinically active in advanced hematologic malignancies

Flinn, I. W., OBrien, S., Kahl, B., Patel, M., Oki, Y., Foss, F. F., Porcu, P., Jones, J., Burger, J. A., Jain, N., Kelly, V. M., Allen, K., Douglas, M., Sweeney, J., Kelly, P., Horwitz, S.
American Society of Hematology (ASH)
Published 2018